You have no items in your shopping cart.
All Products
Human FAP [orb2992826]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 110.9 KDa. Observed: 110-140 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg- Cynomolgus CD93 [orb2992827]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 59 KDa. Observed: 80-100 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human Siglec-2 [orb2992828]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 57.8 KDa. Observed: 75-120 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - FITC-Labeled Human BCMA [orb2992829]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 9.6 KDa. Observed: 15&16-19 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Human PTK7 [orb2992830]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 101.5 KDa. Observed: 120-150 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Mouse NaPi2b (Fluorescent VLP, Full Length) [orb2992831]
SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 77.2 KDa
100 μg, 20 μg - Rhesus Macaque LILRB1 [orb2992832]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 74.6 KDa. Observed: 90-110 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Human CLEC12A [orb2992833]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 24.6 KDa. Observed: 30-58 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human FOLR1 [orb2992834]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 53.4 KDa. Observed: 61-73 KDa, reducing conditions
100 μg, 20 μg Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 49.1 KDa. Observed: 49-64 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg